
SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK
Description
About SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK
The SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) Nucleoprotein Peptide (IEDB: 33667) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Nucleoprotein Peptide, H-KTFPPTEPK-OH (Uniprot: P0DTC9 aa: 361-369) from JPT is produced under strict quality control and quality management.
SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK - Specifications
- Peptide sequence: H-KTFPPTEPK-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Covid-19
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK
References:
Read References with JPT’s Antigen Peptides
SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK has been described in:
Broad and strong memory CD4<sup>+</sup> and CD8<sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19., Nat Immunol, 2020 (PMID: 32887977)
Unbiased Screens Show CD8<sup>+</sup> T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein., Immunity, 2020 (PMID: 33128877)
Exploration of peptides bound to MHC class I molecules in melanoma., Pigment Cell Melanoma Res, 2015 (PMID: 25645385)
Documentation
Documentation for SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK
Properties
Properties of SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Covid-19 |
Layout: | Freeze-dried in glass vial |
Organism: | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Protein Name: | Nucleoprotein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK
Information | Values |
---|---|
Sequence: | H-KTFPPTEPK-OH |
Specifications: | 9mer peptide as TFA salt |